Active specific immunotherapy with a polyvalent cancer vaccine prolongs survival in AJCC stage IV melanoma
Year: 2004
Type: conference-abstract
Source: Journal of Clinical Oncology
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2230342983
